trial · primary record
Rifampicin
Tuberculosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 230 |
| Primary completion | 2031-02 |
| Primary endpoint | Step 2: Unfavorable TB treatment outcome |
| Registry ID | NCT07656012 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:42:51.265Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07656012
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.